| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |